- MiMedx (MDXG) — which recently found itself at the center of a rather unpleasant HCT/P debate with the FDA — inks a distribution agreement with Medtronic (MDT) for the marketing of Purion allografts by an MDT subsidiary.
- MDT's market presence will ensure broader access to the products, something MDXG is "very excited" about. (PR)
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs